Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on PLUTUS POWERGEN PLC. We currently have 3 research reports from 1 professional analysts.
|02Mar17 07:00||RNS||Response to OFGEM Statement|
|20Feb17 07:00||RNS||Appointment of Nominated Adviser and Broker|
|19Jan17 07:00||RNS||Interim Results|
|12Dec16 07:00||RNS||CM Contracts Awarded for 3 UK 20MW Sites|
|21Nov16 07:00||RNS||Indicative Partnership with Big Six Utility|
|09Nov16 12:05||RNS||First Power Sales from 20MW Plymouth Site|
|03Nov16 07:00||RNS||Commissions First 20MW Energy Site in the UK|
Frequency of research reports
Research reports on
PLUTUS POWERGEN PLC
PLUTUS POWERGEN PLC
19 Oct 16
Eco Animal Health (EAH.L) | Tern (TERN.L) | A r i a n a R e s o u r c e s (AAU.L) | Taptica International (TAP.L) | Hotel Chocolat (HOTC.L) | P l u t u s P o w e r G e n (PPG.L) | Feedback (FDBK.L) | GW Pharmaceuticals (GWP.L) | Advanced Oncotherapy (AVO.L) | O n e V i e w G r o u p (ONEV.L)
29 Sep 16
Cambridge Cognition Holdings* (COG.L) | Edenville Energy (EDL.L) | Avingtrans (AVG.L) | Gaming Realms (GMR.L) | Redstone Connect (REDS.L) | Concurrent Technologies (CNC.L) | Porta Communications (PTCM.L) | Galantas Gold (GAL.L) | Range Resources (RRL.L) | Plutus Power Gen (PPG.L)
Happy Birthday AIM: it’s tough being the middle child
02 Dec 15
Going into 2015, AIM had monumental expectations. 2014 was a record breaking year for London’s junior market with IPOs across the year raising £2.4bn (the largest since AIM’s inception). AIM’s 20th year made for a perfect battle ground between the bull and bear camps once more. The bulls, hailing the success of the world’s most successful growth market referencing Big Yellow, IP Group, Domino’s Pizza and of course ASOS. The bears, swiftly retorting back sending shudders down the spines of investors everywhere with the sounds of Quindell, Globo, Adgorithms, and of course where would they be without the mention of a handful of China frauds.
Another positive verdict
20 Mar 17
Burford’s results for 2016 produced another outstanding set of figures. Revenue grew by 60% to $163.4m with strong growth in the litigation finance business and an additional boost from a secondary sale in the Petersen case. On an underlying basis net income grew to $114m, a 75% increase despite the investment in growing capacity which increased costs. A combination of ongoing investment and gains and increases on valuation saw the fair value of the litigation assets increase 67% to $559m, underpinned by a growth in invested capital to $394m. With the results statement there was an announcement of a further sale of 9% of the Petersen case at a valuation of 20 times the cost of investment.
N+1 Singer - Morning Song 22-03-2017
22 Mar 17
Carador Income Fund (CIFU LN) Premium rating restored, high levels of refinancing activity | Cello Group (CLL LN) Outlook getting brighter – watch Pulsar | Eckoh (ECK LN) Largest ever US secure payments win | eg solutions (EGS LN) Full year results in line | Futura Medical (FUM LN) Licensing deal for CSD500 in Portugal | Verona Pharma (VRP LN) Global agreement with QuintilesIMS to support development of RPL554 | Xaar (XAR LN) 2016 results slightly ahead, reduced visibility in 2017
Small Cap Breakfast
21 Mar 17
First Sentinel—Investment company expecting NEX admission/introduction on 24 March. £636k raised pre-IPO. BioPharma Credit—Expected Gross Initial Acquisition Proceeds now c.$338m. Gross Cash Proceeds capped at $423m with placing and open offer. Results expected 23 March with admission now due 30 march. Tufton Oceanic Assets- The Company intends to invest in a diversified portfolio of second hand commercial sea-going vessels where the Investment Manager believes that an attractive opportunity exists in shipping. $150m raise. Admission 3 April.